If it is a short enough time, it is not going to be worth the amount of money that the manufacturer--well, they are not manufacturers; they are more like what I would call hedge fund pharmaceutical companies--would pay to get the rights to that drug.
Discussing the impact of expedited drug approvals on pharmaceutical companies' pricing strategies.
Share
More from Susan Collins
He’s the one that needs to respond to the reports. I’m not going to comment on them. But I will say that based on widespread reporting it appears that he struggles to control his temper.
the fact remains that there are must-pay bills and urgent requirements facing the department that affect the ability of our troops to be well trained and more broadly of the U.S. military to deter and defend against potential aggressors…
But to be fair to the Department of Homeland Security, they couldn’t enter into contracts when the government was shut down by the Democrats.
I was pleased that the bill prevents the OMB from implementing its proposed rule, which would politicize grants and harm small, rural communities, families, and biomedical research.
Other voices in this conversation
